Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Gilles Paintaud

1-50 of 137 results

Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease

scientific article published on 05 August 2009

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

scientific article published on 22 September 2011

Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship.

scientific article published in July 2004

Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output

scientific article

Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease.

scientific article published in March 2004

Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases

scientific article published on 27 June 2011

Infliximab pharmacokinetics in inflammatory bowel disease patients.

scientific article published in August 2008

Mechanism-based pharmacokinetic-pharmacodynamic modeling-a new classification of biomarkers

scientific article published on 24 August 2005

Pharmacokinetics of rituximab and its clinical use: thought for the best use?

scientific article published on 6 February 2007

An enzyme-linked immunosorbent assay for therapeutic drug monitoring of infliximab.

scientific article

Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease

scientific article

Use of [(18)F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [(18)F]-FDG PET-predicted non-responders (AVATA

scientific article

Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritis

scientific article published on July 1, 2014

Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration

scientific article published on 01 July 1996

Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis

scientific article published on 28 June 2015

Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium

scientific article

Evaluation of a peptide ELISA for the detection of rituximab in serum.

scientific article published on 17 July 2007

Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system.

scientific article published on 17 October 2014

Simultaneous estimation of cyclosporin and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy.

scientific article published in January 2002

Methodological issues in pharmacokinetic-pharmacodynamic modelling.

scientific article published in August 1998

Influence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitis

scientific article published on January 1, 2012

Pharmacokinetics and concentration-effect relationship of adalimumab in rheumatoid arthritis

scientific article

Nonlinearity of amoxicillin absorption kinetics in human.

scientific article published in January 1992

The airways, a novel route for delivering monoclonal antibodies to treat lung tumors.

scientific article published on 14 April 2011

Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis

scientific article

IgG1 Allotypes Influence the Pharmacokinetics of Therapeutic Monoclonal Antibodies through FcRn Binding

scientific article published on 18 December 2015

Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report

scientific article published in March 2017

Cetuximab pharmacokinetics influences progression-free survival of metastatic colorectal cancer patients

scientific article published on 27 September 2011

Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study

scientific article published on June 3, 2011

Assessment of the Influence of Inflammation and FCGR3A Genotype on Infliximab Pharmacokinetics and Time to Relapse in Patients with Crohn's Disease

scientific article published on 01 May 2015

Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects.

scientific article published on 29 November 2007

Discrepancy between bioavailability as estimated from urinary recovery of frusemide and total diuretic effect

scientific article

The underlying inflammatory chronic disease influences infliximab pharmacokinetics

scientific article published on 9 August 2016

Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study

scientific article published on 08 November 2016

Influence ofFCGRTgene polymorphisms on pharmacokinetics of therapeutic antibodies

scientific article published on April 25, 2013

Development of a drug-disease simulation model for rituximab in follicular non-Hodgkin's lymphoma.

scientific article published on October 2009

Prediction of methotrexate elimination after high dose infusion in children with acute lymphoblastic leukaemia using a population pharmacokinetic approach.

scientific article published in January 1999

Partial response to bevacizumab of an extensive cutaneous angiosarcoma of the face

scientific article published on 12 April 2010

ELLIPSE Study: a Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia

scientific article

Higher exposure to mycophenolic acid with sirolimus than with cyclosporine cotreatment.

scientific article published in July 2005

Trough infliximab concentrations predict efficacy and sustained control of disease activity in rheumatoid arthritis

scientific article published on 01 April 2010

Can sciatica induced by disc herniation be treated with tumor necrosis factor alpha blockade?

scientific article published on December 2007

The time of maximum effect for model selection in pharmacokinetic– pharmacodynamic analysis applied to frusemide

scientific article published on January 1, 1998

Skin localization of alveolar echinococcosis of the liver

scientific article published on 01 May 1996

Therapeutic antibodies in ophthalmology: old is new again

scientific article published on March 2010

Orthotopic liver transplantation for incurable alveolar echinococcosis of the liver: Report of 17 cases

scientific article published on 01 June 1991

Separation of fifteen non-steroidal anti-inflammatory drugs using micellar electrokinetic capillary chromatography

scientific article published on 01 July 1994

The influence of food intake on the effect of two controlled release formulations of furosemide.

scientific article published in April 1995

Dose-dependent absorption of amoxicillin in patients with an ileostomy

scientific article published on 01 January 1992

No association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohn's disease

scientific article published on 01 January 2006